LIVZON PHARMA (01513) spent 8.7832 million yuan on September 24 to repurchase 250,000 shares of A shares.
Lizhu Pharmaceutical (01513) announced that the company invested 8.7832 million yuan on September 24, 2024...
LIVZON PHARMA (01513) announced that the company spent 8.7832 million yuan to repurchase 250,000 A shares on September 24, 2024. The repurchase price was between 34.95 yuan and 35.76 yuan per share.
Related Articles
In 2025, DUALITYBIO-B(09606) achieved approximately 1.852 billion yuan in revenue, with significant progress in pipeline development and business operations.
Nations Technologies Inc. (02701) added to the "Stock Connect" securities list.
New stock news | Bao Gai New Materials' Hong Kong stock IPO has been approved by the China Securities Regulatory Commission.
In 2025, DUALITYBIO-B(09606) achieved approximately 1.852 billion yuan in revenue, with significant progress in pipeline development and business operations.
Nations Technologies Inc. (02701) added to the "Stock Connect" securities list.
New stock news | Bao Gai New Materials' Hong Kong stock IPO has been approved by the China Securities Regulatory Commission.
